Prior to Auspex, Mr Grey was president and CEO of SGX Pharmaceuticals, which was recently acquired by Eli Lilly. Prior to joining SGX, Mr Grey was president and CEO of Trega Biosciences, which was acquired by Lion bioscience.
Before joining Auspex, Mr Gilmore was CFO of Althea Technologies, a contract manufacturing organization servicing the pharmaceutical and biotechnology industries. Prior to Althea, Mr Gilmore was CFO for Preventsys, which was acquired by McAfee.
Pratik Shah, chairman of Auspex, said: “We are pleased to have Mike and Gary join the Auspex team. Mike’s extensive experience and track record in building companies involved in drug discovery, development, and commercialization, along with Gary’s many years as a senior corporate finance executive, will be invaluable in leading Auspex in the next phase of its development.”